![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Edmond Pharma S.r.l. Paderno Dugnano It, based in Sweden, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Recipharm has the brightest minds in the CDMO industry, from early development to commercial manufacturing.
One of their significant offerings is Glimepiride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2007-180 - Rev 01
This Chemical Type CEP, issued on April 24, 2015, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2223 associated with this CEP further emphasizes